PeptideDB

IRAK-IN-6 1042672-97-8

IRAK-IN-6 1042672-97-8

CAS No.: 1042672-97-8

IRAK-IN-6, formerly known as IRAK inhibitor 6, is an interleukin-1 receptor associated kinase 4 (IRAK-4) inhibitor. IRAK
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

IRAK-IN-6, formerly known as IRAK inhibitor 6, is an interleukin-1 receptor associated kinase 4 (IRAK-4) inhibitor. IRAK-4 is reported to be essential for the activation of the intracellular signalling cascades including NFКB and MAPK pathways, which are critical for the production of inflammatory cytokines.



Physicochemical Properties


Molecular Formula C20H20N4O3S
Molecular Weight 396.46
Exact Mass 396.125
CAS # 1042672-97-8
Related CAS # 1042672-97-8;
PubChem CID 44449392
Appearance Light brown to brown solid powder
Density 1.3±0.1 g/cm3
Index of Refraction 1.652
LogP 1.59
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 7
Rotatable Bond Count 5
Heavy Atom Count 28
Complexity 520
Defined Atom Stereocenter Count 0
InChi Key JQSRUVXPODZKAF-UHFFFAOYSA-N
InChi Code

InChI=1S/C20H20N4O3S/c1-26-18-11-15(24-7-9-27-10-8-24)4-5-16(18)22-19(25)17-13-28-20(23-17)14-3-2-6-21-12-14/h2-6,11-13H,7-10H2,1H3,(H,22,25)
Chemical Name

N-[2-Methoxy-4-(4-morpholinyl)phenyl]-2-(3-pyridinyl)-4-thiazolecarboxamide
Synonyms

IRAK-IN-6 IRAK IN 6 IRAKIN6 IRAK inhibitor 6
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro IRAK inhibitor 6 is the most potent of these drugs tested; potency additive, IRAK inhibitor 6 considerably improves potency against IRAK-4 [1].
References

[1]. IRAK-4 inhibitors. Part 1: a series of amides. Bioorg Med Chem Lett. 2008 Jun 1;18(11):3211-4.


Solubility Data


Solubility (In Vitro) DMSO : ~8.33 mg/mL (~21.01 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 0.83 mg/mL (2.09 mM) (saturation unknown) in 10% DMSO + 40% PEG300 +5% Tween-80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 8.3 mg/mL clear DMSO stock solution to 400 μL of PEG300 and mix evenly; then add 50 μL of Tween-80 + to the above solution and mix evenly; then add 450 μL of normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.5223 mL 12.6116 mL 25.2232 mL
5 mM 0.5045 mL 2.5223 mL 5.0446 mL
10 mM 0.2522 mL 1.2612 mL 2.5223 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.